Yüklüyor......
Tivozanib in the treatment of renal cell carcinoma
Renal cell carcinoma (RCC) is an aggressive malignancy compared to other urological malignancies and has been associated with poor responses to conventional cytotoxic chemotherapy. Interferon-α and interleukin-2 were previously utilized in a limited number of patients with good performance status du...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3684142/ https://ncbi.nlm.nih.gov/pubmed/23788831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S32958 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|